Renaissance Technologies's IBB Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 27,482 shares of iShares Biotechnology ETF (IBB) worth $3.97 M, representing 0.01% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 33,400 shares. Largest reduction occurred in Q3 2022, reducing 24,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2019 | +10,300 | New Buy | 10,300 | $111.84 |
| Q2 2019 | +9,500 | Add 92.23% | 19,800 | $109.09 |
| Q3 2019 | -19,800 | Sold Out | 19,800 | $109.09 |
| Q4 2019 | +4,700 | New Buy | 4,700 | $120.43 |
| Q1 2020 | -4,700 | Sold Out | 4,700 | $120.43 |
| Q4 2020 | +10,795 | New Buy | 10,795 | $151.46 |
| Q1 2021 | -10,795 | Sold Out | 10,795 | $151.46 |
| Q1 2022 | +1,600 | New Buy | 1,600 | $130.00 |
| Q2 2022 | +33,400 | Add 2087.50% | 35,000 | $117.63 |
| Q3 2022 | -24,400 | Reduce 69.71% | 10,600 | $116.98 |
| Q4 2022 | -10,600 | Sold Out | 10,600 | $116.98 |
| Q1 2023 | +12,500 | New Buy | 12,500 | $0.13 |
| Q2 2023 | -12,500 | Sold Out | 12,500 | $0.13 |
| Q4 2024 | +13,100 | New Buy | 13,100 | $132.21 |
| Q1 2025 | -13,100 | Sold Out | 13,100 | $132.21 |
| Q3 2025 | +27,482 | New Buy | 27,482 | $144.37 |
Renaissance Technologies's iShares Biotechnology ETF Investment FAQs
Renaissance Technologies first purchased iShares Biotechnology ETF (IBB) in Q1 2019, acquiring 10,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held iShares Biotechnology ETF (IBB) for 27 quarters since Q1 2019.
Renaissance Technologies's largest addition to iShares Biotechnology ETF (IBB) was in Q2 2022, adding 35,000 shares worth $4.12 M.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 27,482 shares of iShares Biotechnology ETF (IBB), valued at approximately $3.97 M.
As of the Q3 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in iShares Biotechnology ETF (IBB) was 35,000 shares, as reported at the end of Q2 2022.